Delivery Order SPE2DB22D2108-SPE2DB25FU5PR
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.73, is for the delivery of oxcarbazepine 300 mg/5 ml suspension, a generic anticonvulsant medication, with a completion date of February 25, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,568.42 contract is for the supply of 250 ml bottles of the medication Oxcarbazepine 300 mg/5 ml suspension. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mL of Oxcarbazepine 300mg/5mL suspension. As a prime contractor on an indefinite delivery/indefinite quantity pharmaceuticals contract, Amerisourcebergen will deliver the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The firm-fixed-price contract has a ceiling value of $1,324.26 and a completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award, valued at $2,066.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract has a firm fixed price and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units, with a ceiling value of $3,449.47 and firm fixed pricing. This delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 1, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a continuation of the vendor's established...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract, valued at $3,268.33, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of October 30, 2023 and was awarded on October 27, 2022. This contract is not...